These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 1657673

  • 1. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM.
    Hirsch IB, Boyle PJ, Craft S, Cryer PE.
    Diabetes; 1991 Sep; 40(9):1177-86. PubMed ID: 1657673
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
    Towler DA, Havlin CE, Craft S, Cryer P.
    Diabetes; 1993 Dec; 42(12):1791-8. PubMed ID: 8243825
    [Abstract] [Full Text] [Related]

  • 3. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA, Shah SD, Cryer PE.
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [Abstract] [Full Text] [Related]

  • 4. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P.
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [Abstract] [Full Text] [Related]

  • 5. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
    Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE.
    Diabetes Care; 1998 Nov; 21(11):1939-43. PubMed ID: 9802747
    [Abstract] [Full Text] [Related]

  • 6. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
    Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Brunetti P, Bolli GB.
    Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
    [Abstract] [Full Text] [Related]

  • 7. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
    Dagogo-Jack S, Rattarasarn C, Cryer PE.
    Diabetes; 1994 Dec; 43(12):1426-34. PubMed ID: 7958494
    [Abstract] [Full Text] [Related]

  • 8. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
    Rattarasarn C, Dagogo-Jack S, Zachwieja JJ, Cryer PE.
    Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT, Simonson DC.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [Abstract] [Full Text] [Related]

  • 10. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.
    Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E.
    Diabetologia; 1994 Dec; 37(12):1265-76. PubMed ID: 7895957
    [Abstract] [Full Text] [Related]

  • 11. α- or β-Adrenergic blockade does not affect transplanted islet cell responses to hypoglycemia in type 1 diabetes.
    Rickels MR, Bellin MD, Stefanovski D, Peleckis AJ, Dalton-Bakes C, Markmann E, Nguyen HL, Townsend RR, Hering BJ, Naji A.
    Am J Physiol Endocrinol Metab; 2024 Sep 01; 327(3):E290-E301. PubMed ID: 38984949
    [Abstract] [Full Text] [Related]

  • 12. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.
    Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, Cryer PE.
    Diabetes; 1998 Dec 01; 47(12):1920-7. PubMed ID: 9836525
    [Abstract] [Full Text] [Related]

  • 13. Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Weinger K, Jacobson AM, Draelos MT, Finkelstein DM, Simonson DC.
    Am J Med; 1995 Jan 01; 98(1):22-31. PubMed ID: 7825615
    [Abstract] [Full Text] [Related]

  • 14. Hypoglycemia unawareness in IDDM.
    Mokan M, Mitrakou A, Veneman T, Ryan C, Korytkowski M, Cryer P, Gerich J.
    Diabetes Care; 1994 Dec 01; 17(12):1397-403. PubMed ID: 7882808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.
    Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE.
    N Engl J Med; 1988 Jun 09; 318(23):1487-92. PubMed ID: 3285214
    [Abstract] [Full Text] [Related]

  • 17. Oral propranolol and metoprolol both impair glucose recovery from insulin-induced hypoglycemia in insulin-dependent diabetes mellitus.
    Popp DA, Tse TF, Shah SD, Clutter WE, Cryer PE.
    Diabetes Care; 1984 Jun 09; 7(3):243-7. PubMed ID: 6376017
    [Abstract] [Full Text] [Related]

  • 18. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
    Davis MR, Mellman M, Shamoon H.
    Diabetes; 1992 Oct 09; 41(10):1335-40. PubMed ID: 1397708
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.